1. 1 Emerging Disease Surveillance and Response (ESR) WHO Western Pacific Regional Office (WPRO) Introduction to Group Work 1 Quality Assurance Programmes

2. 2 Emerging Disease Surveillance and Response (ESR) WHO Western Pacific Regional Office (WPRO) Group Work 1 Group A VIP Room Group B Lobby Group C 7 th Floor Group D Grand Ballroom Philippe Buchy Ung Sam An Ly Sovann Seng Heng Zhen Xu Xia Gang Prem Sanjeev Singh Dong Wang (Christine) Lo Yee Chi (Janice) Nobuhiko Okabe B Khamphaphongphane P Vongphrachanh S Archkawongs Chong Chee Kheong Norizah Ismail Oyuntsetseg Purev Dulmaa Nyamkhuu Alyeksander Burmaa Anne-Claire Gourinat Jean Paul Grangeon Sue Huang Chun Kang Jinwoong MOON Park Sunhee Nguyen Thanh Long Domanh Hung Nguyen Le Khanh Hang Vu Ngoc Long Vito Roque Remigio Olveda Juan Lopez Phoebe Lee Wen Lim Nancy Tee MS Haider Kim Jong Hwan Ro Nam Chol Khin Yi Oo Anand Shrestha S Waicharoen G Wickramasinghe Ondri Dwi Sampurno Vivi Setiawaty Dapeng Luo Takato Odagiri Seiichiro Fujisaki Wang Dayan Jeff McFarland Boris Pavlin Ian Barr Aeron Hurt Xu Xiyan Andrew Corwin Babatunde Olowokure Anne Kelso Lance Jennings Patrick Reading Harpal Singh Oomen John Wilina Lim Ann Moen Sonja Olsen

3. 3 Emerging Disease Surveillance and Response (ESR) WHO Western Pacific Regional Office (WPRO) Plenary - Feedback at 09:45

4. 4 Emerging Disease Surveillance and Response (ESR) WHO Western Pacific Regional Office (WPRO) Current WHO EQAP for detection of influenza A by PCR Strengths? Only currently widely available Q/A WHO System. Well organized. Timely Weaknesses? Timing could be improved to accommodate seasonality. Areas to improve? Including an influenza virus that is not commonly recognized (H7 and H9). Build in a challenge to the system (possibly including untypeables).

5. 5 Emerging Disease Surveillance and Response (ESR) WHO Western Pacific Regional Office (WPRO) Other programmes: do you participate in the following? List the labs participating in the following programmes Fee-paying: –QCMD: NCLE (Lao PDR) –NEQAS: –CAP Free: –CDC: Performance Evaluation Program (PEP) Development In Progress (hopefully by end of 2011/early 2012. NCLE will participate in Piloting. Strengths and Weaknesses of the above programmes

6. 6 Emerging Disease Surveillance and Response (ESR) WHO Western Pacific Regional Office (WPRO) Scope of EQAP: Needs to be expanded? Virus culture NEAR TERM Antivirals (phenotypic or genotypic) LONG TERM Sequencing MID TERM Serology LONG TERM Others Which labs/NICs are doing each of the above? NONE! What methods? If currently not doing, any plan in the mid-term or long term? –If offered, many NIC’s would be interested. Priority of launching programme? TOP Priority – Virus Culture.

7. 7 Emerging Disease Surveillance and Response (ESR) WHO Western Pacific Regional Office (WPRO) Preferred features of EQAP? Number of samples: –current number satisfactory. Type of samples: –current type satisfactory. Frequency: Better –accommodate seasonality. Time to reporting: –current timing satisfactory. Format of reports: –Better to provide template that can be electronically edited and sent. Others